Published in BMJ on June 29, 2007
Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics | NCT00870012
The Influence of Probiotics on Vancomycin-Resistant Enterococcus | NCT00591474
Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat Rev Microbiol (2008) 3.25
Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96
An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol (2010) 1.58
Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study. BMJ Open (2015) 1.42
Aging of the human metaorganism: the microbial counterpart. Age (Dordr) (2011) 1.36
Antibiotics, microbiota, and immune defense. Trends Immunol (2012) 1.33
Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol (2009) 1.28
Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis (2008) 1.27
Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B. Infect Immun (2011) 1.24
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide. Aliment Pharmacol Ther (2013) 1.21
Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition. J Clin Microbiol (2010) 1.21
Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr (2011) 1.17
Bench-to-bedside review: Clostridium difficile colitis. Crit Care (2008) 1.08
Prebiotic and probiotic fortified milk in prevention of morbidities among children: community-based, randomized, double-blind, controlled trial. PLoS One (2010) 1.08
Does eating yogurt prevent antibiotic-associated diarrhoea? A placebo-controlled randomised controlled trial in general practice. Br J Gen Pract (2007) 1.06
Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol (2011) 1.05
Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole. PLoS One (2013) 1.03
Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr (2010) 1.02
Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol (2010) 0.99
Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog (2009) 0.99
New advances in the treatment of Clostridium difficile infection (CDI). Ther Clin Risk Manag (2008) 0.98
Efficacy of BIO K+ CL1285 in the reduction of antibiotic-associated diarrhea - a placebo controlled double-blind randomized, multi-center study. Arch Med Sci (2010) 0.98
New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis (2015) 0.97
A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol (2012) 0.96
Emergency subtotal colectomy for fulminant Clostridium difficile colitis--is a surgical solution considered for all patients? Ann R Coll Surg Engl (2010) 0.93
Recommendations for probiotic use in humans-a 2014 update. Pharmaceuticals (Basel) (2014) 0.92
Enteric pathogens through life stages. Front Cell Infect Microbiol (2012) 0.91
Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile infection among hospitalized patients: systematic review and meta-analysis. Open Med (2013) 0.91
Prevention and treatment of urinary tract infection with probiotics: Review and research perspective. Indian J Urol (2008) 0.90
Effects of probiotics on acquisition and spread of multiresistant enterococci. Antimicrob Agents Chemother (2010) 0.90
Preventive effects of different probiotic formulations on travelers' diarrhea model in wistar rats : preventive effects of probiotics on TD. Dig Dis Sci (2009) 0.89
Prescribing antibiotics in primary care. BMJ (2007) 0.89
Selected commensal-related bacteria and Toll-like receptor 3 agonist combinatorial codes synergistically induce interleukin-12 production by dendritic cells to trigger a T helper type 1 polarizing programme. Immunology (2008) 0.88
Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol (2016) 0.86
Probiotics in clostridium difficile Infection. J Clin Gastroenterol (2011) 0.86
Saccharomyces boulardii to Prevent Antibiotic-Associated Diarrhea: A Randomized, Double-Masked, Placebo-Controlled Trial. Open Forum Infect Dis (2016) 0.86
Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine. BMC Microbiol (2012) 0.85
Diarrhoea associated with antibiotic use. BMJ (2007) 0.84
Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med (2016) 0.83
The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures. Pharmaceuticals (Basel) (2014) 0.83
The prebiotic concept and human health: a changing landscape with riboflavin as a novel prebiotic candidate? Eur J Clin Nutr (2016) 0.83
Effect of probiotic Lactobacillus (Lacidofil® cap) for the prevention of antibiotic-associated diarrhea: a prospective, randomized, double-blind, multicenter study. J Korean Med Sci (2010) 0.83
Probiotics for antibiotic-associated diarrhea: do we have a verdict? World J Gastroenterol (2014) 0.83
Review on microbiota and effectiveness of probiotics use in older. World J Clin Cases (2015) 0.83
Influence of probiotics on Candida presence and IgA anti-Candida in the oral cavity. Braz J Microbiol (2009) 0.82
Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs (2010) 0.82
Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production. Gut Microbes (2012) 0.82
Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J Gastrointest Pharmacol Ther (2014) 0.81
Anti-inflammatory and Intestinal Barrier-protective Activities of Commensal Lactobacilli and Bifidobacteria in Thoroughbreds: Role of Probiotics in Diarrhea Prevention in Neonatal Thoroughbreds. J Equine Sci (2014) 0.81
Identification and characterisation of an iron-responsive candidate probiotic. PLoS One (2011) 0.80
Overview of Clostridium difficile infection: implications for China. Gastroenterol Rep (Oxf) (2013) 0.79
Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. World J Gastroenterol (2014) 0.79
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev (2017) 0.78
Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations. Transpl Infect Dis (2016) 0.78
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol (2016) 0.78
Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells. Genes Nutr (2014) 0.77
Nutrition economics: towards comprehensive understanding of the benefits of nutrition. Microb Ecol Health Dis (2012) 0.77
Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for? Anaerobe (2016) 0.77
Probiotics in the management of lung diseases. Mediators Inflamm (2013) 0.77
Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial-PROSPECT: protocol for a feasibility randomized pilot trial. Pilot Feasibility Stud (2015) 0.77
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review. Antibiotics (Basel) (2015) 0.77
Probiotics and diarrhea: Data are not widely applicable. BMJ (2007) 0.76
Probiotics and diarrhea: No high risk antibiotics? BMJ (2007) 0.76
Clinical Uses of Probiotics. Medicine (Baltimore) (2016) 0.76
Lactobacillus acidophilus stimulates intestinal P-glycoprotein expression via a c-Fos/c-Jun-dependent mechanism in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2016) 0.76
A probiotic drink prevented diarrhoea and Clostridium difficile infection in older patients taking antibiotics. Evid Based Med (2008) 0.75
Lactobacillus probiotics in the prevention of diarrhea associated with Clostridium difficile: a systematic review and Bayesian hierarchical meta-analysis. CMAJ Open (2016) 0.75
Infectious disease. Probiotics for the prevention of diarrhea associated with antibiotics. Rev Gastroenterol Disord (2008) 0.75
A probiotic drink prevented diarrhoea and Clostridium difficile-associated diarrhoea in older patients taking antibiotics. Evid Based Nurs (2008) 0.75
Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent. Biomed Res Int (2013) 0.75
Probiotics and diarrhea: No proton pump inhibitors? BMJ (2007) 0.75
Antibiotic precautions in athletes. Sports Health (2014) 0.75
Mismatch between Probiotic Benefits in Trials versus Food Products. Nutrients (2017) 0.75
Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing (1972) 10.94
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis (2001) 6.92
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ (2002) 5.36
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol (2006) 4.87
Clostridium difficile infection. Annu Rev Med (1998) 3.63
Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet (1994) 3.62
In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr (2001) 2.73
Probiotics. Int J Food Microbiol (1998) 2.52
Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect (2001) 2.45
Probiotic use in clinical practice: what are the risks? Am J Clin Nutr (2006) 2.44
Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect (1996) 2.34
Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr (1995) 2.30
Treatment and prevention of antibiotic associated diarrhea. Int J Antimicrob Agents (2000) 1.80
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther (2002) 1.73
Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm (1979) 1.72
A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP (1990) 1.63
Probiotics and gastrointestinal diseases. J Intern Med (2005) 1.47
The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int J Clin Pract (2000) 1.44
Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int J Clin Pract (2000) 1.36
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ (2002) 5.36
Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med (2010) 3.05
Population-based multidimensional assessment of older people in UK general practice: a cluster-randomised factorial trial. Lancet (2004) 2.96
Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension (2010) 2.93
Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing (2006) 2.44
Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr (2006) 2.19
Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clin Sci (Lond) (2003) 2.07
Does white coat hypertension require treatment over age 80?: Results of the hypertension in the very elderly trial ambulatory blood pressure side project. Hypertension (2012) 2.03
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens (2004) 1.87
Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol (2010) 1.76
On-treatment diastolic blood pressure and prognosis in systolic hypertension. Arch Intern Med (2007) 1.75
Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens (2003) 1.74
CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis (2009) 1.74
Estimation of central aortic pressure by SphygmoCor requires intra-arterial peripheral pressures. Clin Sci (Lond) (2003) 1.55
Living wills and the Mental Capacity Act: a postal questionnaire survey of UK geriatricians. Age Ageing (2006) 1.44
The human immunodeficiency virus and ageing. Age Ageing (2014) 1.42
Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med (2002) 1.42
A role for TLR4 in Clostridium difficile infection and the recognition of surface layer proteins. PLoS Pathog (2011) 1.39
Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4. Nephrol Dial Transplant (2010) 1.39
Validity of the Clock-Drawing Test as a screening tool for cognitive impairment in the elderly. Am J Epidemiol (2004) 1.30
Factors associated with depression in a representative sample of 14 217 people aged 75 and over in the United Kingdom: results from the MRC trial of assessment and management of older people in the community. Int J Geriatr Psychiatry (2003) 1.28
Detection and investigation of invasive mould disease. J Antimicrob Chemother (2011) 1.27
Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension (2004) 1.27
The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care (2003) 1.26
Ethnic differences in vascular stiffness and relations to hypertensive target organ damage. J Hypertens (2004) 1.18
Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates. J Clin Microbiol (2010) 1.17
Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing (2013) 1.03
Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant (2011) 1.02
Are older people dying of depression? Findings from the Medical Research Council trial of the assessment and management of older people in the community. J Am Geriatr Soc (2005) 1.01
Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension. Am J Hypertens (2002) 0.99
Candida glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced filamentation. Mol Microbiol (2003) 0.98
Ethnic differences in skin microvascular function and their relation to cardiac target-organ damage. J Hypertens (2005) 0.97
Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension (2012) 0.97
Drug cessation in complex older adults: time for action. Age Ageing (2013) 0.95
Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing. MBio (2015) 0.93
Adverse drug reactions in elderly: challenges in identification and improving preventative strategies. Age Ageing (2009) 0.93
The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro. PLoS One (2011) 0.93
Association of quality of life in old age in Britain with socioeconomic position: baseline data from a randomised controlled trial. J Epidemiol Community Health (2004) 0.93
Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study. Psychoneuroendocrinology (2004) 0.92
Cardiovascular and biochemical risk factors for incident dementia in the Hypertension in the Very Elderly Trial. J Hypertens (2009) 0.92
FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart. Nephrol Dial Transplant (2011) 0.91
Terminal digit preference and single-number preference in the Syst-Eur trial: influence of quality control. Blood Press Monit (2002) 0.91
Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies. Clin Chim Acta (2011) 0.90
Serum calcification propensity predicts all-cause mortality in predialysis CKD. J Am Soc Nephrol (2013) 0.89
Comparison of two DNA microarrays for detection of plasmid-mediated antimicrobial resistance and virulence factor genes in clinical isolates of Enterobacteriaceae and non-Enterobacteriaceae. Int J Antimicrob Agents (2010) 0.89
Increased arterial stiffness in Europeans and African Caribbeans with type 2 diabetes cannot be accounted for by conventional cardiovascular risk factors. Am J Hypertens (2006) 0.89
Pathogen-specific DNA enrichment does not increase sensitivity of PCR for diagnosis of invasive aspergillosis in neutropenic patients. J Clin Microbiol (2010) 0.88
CKD and hospitalization in the elderly: a community-based cohort study in the United Kingdom. Am J Kidney Dis (2010) 0.88
Vascular compliance is reduced in vascular dementia and not in Alzheimer's disease. Age Ageing (2008) 0.88
Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction? Diabetes (2005) 0.88
Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation? Clin Chim Acta (2010) 0.87
Quality of life and antihypertensive effect with nebivolol and losartan. Am J Hypertens (2005) 0.87
Adverse drug reactions in a population of hospitalized very elderly patients. Drugs Aging (2012) 0.87
Candida glabrata Ste11 is involved in adaptation to hypertonic stress, maintenance of wild-type levels of filamentation and plays a role in virulence. Med Mycol (2005) 0.87
The relationship between dipping profile in blood pressure and neurologic deficit in early acute ischemic stroke. J Stroke Cerebrovasc Dis (2010) 0.85
Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country. PLoS One (2013) 0.83
Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant Mycobacterium tuberculosis in New Zealand. Genome Announc (2014) 0.83
Repeatability of non-invasive measurement of intracerebral pulse wave velocity using transcranial Doppler. Clin Sci (Lond) (2005) 0.83
Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension. J Hypertens (2004) 0.83
Prevalence of ambulatory hypotension in elderly patients with CKD stages 3 and 4. Nephrol Dial Transplant (2009) 0.83
Real-time PCR and quantitative culture for monitoring of experimental Aspergillus fumigatus intracranial infection in neutropenic mice. J Med Microbiol (2011) 0.83
Candida glabrata Ste20 is involved in maintaining cell wall integrity and adaptation to hypertonic stress, and is required for wild-type levels of virulence. Yeast (2004) 0.83
Abdominal obesity and subclinical vascular damage in the elderly. J Hypertens (2010) 0.82
Geriatric Depression Scale Scores in a representative sample of 14 545 people aged 75 and over in the United Kingdom: results from the MRC Trial of Assessment and Management of Older People in the Community. Int J Geriatr Psychiatry (2002) 0.82
Survival of community-dwelling older people: the effect of cognitive impairment and social engagement. J Am Geriatr Soc (2009) 0.82
Advance end-of-life healthcare planning in an acute NHS hospital setting; development and evaluation of the Expression of Healthcare Preferences (EHP) document. Age Ageing (2008) 0.82
Recurrent strokes caused by a malpositioned pacemaker lead. Age Ageing (2011) 0.81
Comparison of plasmid-mediated quinolone resistance and extended-spectrum β-lactamases in third-generation cephalosporin-resistant Enterobacteriaceae from four Irish hospitals. J Med Microbiol (2011) 0.81
Characterization of Escherichia coli bloodstream isolates associated with mortality. J Med Microbiol (2016) 0.81
Effect of androgen suppression compared with androgen receptor blockade on arterial stiffness in men with prostate cancer. J Androl (2009) 0.81
Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancer. Clin Endocrinol (Oxf) (2007) 0.80
Direct interaction studies between Aspergillus fumigatus and human immune cells; what have we learned about pathogenicity and host immunity? Front Microbiol (2012) 0.80
Enhanced external counterpulsation does not alter arterial stiffness in patients with angina. Clin Cardiol (2004) 0.80
Irbesartan improves arterial compliance more than lisinopril. Vasc Health Risk Manag (2009) 0.80
Deep-seated resistance in relapsed paratyphoid fever. Clin Infect Dis (2006) 0.80
The relationship between androgens and arterial stiffness in older men. J Am Geriatr Soc (2003) 0.79
Probiotics for the prevention and treatment of Clostridium difficile in older patients. Age Ageing (2012) 0.78
How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2). Curr Control Trials Cardiovasc Med (2001) 0.78